Beam Therapeutics BEAM Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's operating income?
- Beam Therapeutics (BEAM) reported operating income of -$107.22M in Q1 2026.
- How has Beam Therapeutics's operating income changed year-over-year?
- Beam Therapeutics's operating income increased by 10.1% year-over-year, from -$119.29M to -$107.22M.
- What is the long-term trend for Beam Therapeutics's operating income?
- Over 3 years (2021 to 2025), Beam Therapeutics's operating income has grown at a -0.8% compound annual growth rate (CAGR), from -$392.47M to -$383.69M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.